Technical Analysis for ADHD - Alcobra Ltd.

Grade Last Price % Change Price Change
grade F 1.13 -0.88% -0.01
ADHD closed down 0.88 percent on Friday, July 21, 2017, on 43 percent of normal volume. It ran into resistance at its 50 day moving average.
Track This Stock
Watchlist Portfolio
Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Strong Down Down Flat
See historical ADHD trend table...

Date Alert Name Type % Chg
Jul 21 50 DMA Resistance Bearish 0.00%
Jul 21 Bollinger Band Squeeze Range Contraction 0.00%
Jul 21 Non-ADX 1,2,3,4 Bearish Bearish Swing Setup 0.00%
Jul 20 50 DMA Resistance Bearish -0.88%
Jul 20 Doji - Bullish? Reversal -0.88%

Older signals for ADHD ...

Get this analysis on your stocks daily!

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio.
Basic chart:

Profile
Alcobra Ltd., a biopharmaceutical company, focuses on the development and commercialization of various drugs for the treatment of neurological disturbance. Its principal product includes MG01CI that has completed Phase II studies to treat attention deficit hyperactivity disorder. The company was founded in 2008 and is headquartered in Tel Aviv, Israel.
Is ADHD a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 1 bullish, 3 bearish and 1 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 5.36
52 Week Low 0.83
Average Volume 217,436
200-Day Moving Average 1.4974
50-Day Moving Average 1.143
20-Day Moving Average 1.128
10-Day Moving Average 1.13
Average True Range 0.0345
ADX 26.41
+DI 16.33
-DI: 14.29
Chandelier Exit (Long, 3 ATRs) 1.0565
Chandelier Exit (Short, 3 ATRs) 1.1935
Upper Bollinger Band 1.1476
Lower Bollinger Band 1.1084
Percent B (%b) 0.55
Bandwidth 0.034752
MACD Line -0.0034
MACD Signal Line -0.0052
MACD Histogram 0.0018